ROCKVILLE, Md. — Emergent BioSolutions Inc. will webcast its presentation at two investor conferences in November.
The presentations will be made on Nov. 11 at the Southwest Ideas Conference in Dallas, and on Nov. 17 at the Lazard Capital Markets Healthcare Conference? in New York.
During each presentation, a member of the company’s senior management team will provide a corporate overview, including a discussion of product development programs, corporate activities and financial performance.
A webcast of these presentations will be available both live and by replay, accessible from the company’s website, www.emergentbiosolutions.com, under “Investors.”
Emergent BioSolutions focuses on vaccines and therapeutics that assist the body’s immune system. Its BioThrax is the only vaccine licensed by the U.S. Food and Drug Administration for the prevention of anthrax disease.
Programs focused on botulism, tuberculosis, typhoid, hepatitis B and Chlamydia are also in development.